StudyFinder

UP0085: A POSTMARKETING, MULTICENTER, LONGITUDINAL, PROSPECTIVE, PHARMACOKINETIC, PHASE 1B STUDY IN PREGNANT WOMEN WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH CIMZIA? (CERTOLIZUMAB PEGOL)

Recruiting

A postmarketing, multicenter, longitudinal, prospective, pharmacokinetic, phase 1B study in pregnant women with chronic inflammatory diseases treated with cimzia

I'm interested

This study is NOT accepting healthy volunteers

Digestive & Liver Health, Axial Spondyloarthritis, Crohn's Disease, Plaque Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis

inflammatory bowel disease, Axial Spondyloarthritis (AxSpA), CZP, Certolizumab Pegol, Cimzia, Clinics and Surgery Center (CSC), Crohn's Disease (CD), Pharmacokinetics, Plaque Psoriasis (PSO), Pregnant Women, Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA)

Ghislaine Feussom - feuss001@umn.edu
Eugenia Shmidt
Phase IV
STUDY00009260
NCT04163016
See this study on ClinicalTrials.gov

Back